Literature DB >> 6246275

Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells.

R J Feighny, M P Farrell, J S Pagano.   

Abstract

Epstein-Barr virus superinfection of the human lymphoblastoid cell line Raji, a Burkitt lymphoma-derived line that contains Epstein-Barr virus genomes in an episomal form, results in the sequential synthesis of 29 detectable proteins, which range in molecular weight from approximately 155,000 to 21,000, and in the shutoff of the bulk of host protein synthesis within 6 to 9 h after infection. There are three classes of virus-induced proteins; these are an early class, consisting of eight proteins synthesized by 6 h postinfection, an intermediate class, containing two proteins synthesized 9 h postinfection, and a late class, consisting of five proteins synthesized 12 h postinfection. In addition, there is a fourth class of polypeptides, called persistent, that are found both before and after superinfection. The rates of synthesis of the proteins fall into three patterns; these are pattern A, in which the rate of synthesis decreases, pattern B, in which the rate of synthesis remains steady, and pattern C, in which the rate of synthesis increases after the initial appearance of the polypeptide. Both 9-(2-hydroxy-ethoxymethyl)guanine (acyclovir) and phosphonoacetic acid inhibit the appearance of one intermediate protein and at least three late proteins. Seven polypeptides are phosphorylated at different times after infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246275      PMCID: PMC288724     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.

Authors:  M Dolyniuk; R Pritchett; E Kieff
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.

Authors:  W C Summers; G Klein
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

3.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

4.  Epstein-Barr virus DNA synthesized in superinfected Raji cells.

Authors:  J E Shaw; T Seebeck; J L Li; J S Pagano
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

5.  Mechanisms of infection with Epstein-Barr virus. III. The synthesis of proteins in superinfected Raji cells.

Authors:  G J Bayliss; M Nonoyama
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

6.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

7.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

8.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

9.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

10.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

View more
  18 in total

1.  A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro.

Authors:  M R Chen; S J Chang; H Huang; J Y Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The regulated expression of Epstein-Barr virus: evidence that the transition from primary to secondary protein synthesis in Raji cells superinfected with Epstein-Barr virus requires the synthesis of new RNA.

Authors:  G J Bayliss; H Wolf
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus.

Authors:  B Vroman; J Luka; M Rodriguez; G R Pearson
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.

Authors:  J C Lin; E I Choi; J S Pagano
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Localization of the coding region for an Epstein-Barr virus early antigen and inducible expression of this 60-kilodalton nuclear protein in transfected fibroblast cell lines.

Authors:  M S Cho; K T Jeang; S D Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

6.  A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein.

Authors:  M S Cho; G Milman; S D Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.

Authors:  M Hummel; E Kieff
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis.

Authors:  R J Feighny; B E Henry; J S Pagano
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

9.  Epstein-Barr virus polypeptides: identification of early proteins and their synthesis and glycosylation.

Authors:  R J Feighny; B E Henry; J S Pagano
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

10.  Filamentous structures associated with Epstein-Barr virus-infected cells.

Authors:  C L Moore; J D Griffith; J E Shaw
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.